Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+20,230,667
Put/Call ratio
25%
SEC-reported price per share
$43.62
Number of holders
208
Value change
+$874,104,377
Number of buys
130
Open additional details 1 more signal available
Number of sells
86
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
445,144,313

Security key

G7709Q104

Report period

Q1 2021

Institutions

208

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAGE CAPITAL PARTNERS GP...
Disclosed value leader
ADAGE CAPITAL PARTNERS GP...
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 8.7% Showing 1-6 of 15 holder rows.

Quick read

ADAGE CAPITAL PARTNERS GP, L.L.C. leads the comparable SEC ownership view at 8.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADAGE CAPITAL PARTNERS GP, L.L.C.'s linked filing trail.
Comparable ownership Top 5
ADAGE CAPITAL PARTNERS GP, L.L.C. 8.7%
FMR LLC 5.6%
MORGAN STANLEY 5.3%
Vantage Consulting Group Inc 4.8%
Capital International Investors 3.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
8.7%
$1,937,650,000
38,714,280 shares
31 Dec 2020
FMR LLC
13F
Company
13F
5.6%
$1,248,374,000
24,942,545 shares
31 Dec 2020
MORGAN STANLEY
13F
Company
13F
5.3%
$1,191,094,000
23,798,081 shares
31 Dec 2020
Vantage Consulting Group Inc
13F
Company
13F
4.8%
$1,074,938,000
21,477,282 shares
31 Dec 2020
Capital International Investors
13F
Company
13F
3.7%
$823,390,000
16,451,353 shares
31 Dec 2020
HARVARD MANAGEMENT CO INC
13F
Company
13F
3.3%
$735,274,000
14,690,780 shares
31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
208
Shares
246,400,511
Rows available
208
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders
208
Q1 2021 holders
208
Holder diff
0
Investor Q1 2021 Shares Q1 2021 Shares Share Diff Share Chg % Q1 2021 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .